Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
91143 trials found · Page 129 of 4558
-
Chilling after heart stopping: could cooling save more brains?
Disease control Not yet recruitingThe IH-TTM trial is designed to determine whether survival with a favorable neurological outcome is improved by induced hypothermia at 33°C in comatose critically ill patients admitted after resuscitated in-hospital cardiac arrest (IHCA). Recent evidence suggests that targeted te…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
New vaccine trial aims to clear Cancer-Causing HPV infections
Disease control Not yet recruitingThis research is being done to test the safety and feasibility of an investigational DNA vaccine called pBI-11 and to find out what effects, if any, it has on women with persistent human papillomavirus 16 (HPV16+) and/or human papillomavirus (HPV18+) cervical infection. The DNA …
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Apr 20, 2026 16:15 UTC
-
Could Late-Stroke patients still benefit from clot removal? new trial aims to find out
Disease control Recruiting nowSELECT LATE trial aims to evaluate if addition of endovascular thrombectomy to medical management in patients presenting with acute ischemic stroke and a proximal large vessel occlusion in the anterior circulation between 24 and 72 hours of stroke onset results in achieving bette…
Phase: NA • Sponsor: Amrou Sarraj • Aim: Disease control
Last updated Apr 26, 2026 19:39 UTC
-
School-Based malaria treatment aims to shield entire villages
Prevention Not yet recruitingThe CRITICal study aims to estimate the effectiveness of intermittent preventive treatment in school children (IPTsc) with dihydroartemisinin-piperaquine (DP) for reducing community level malaria burden. Given that school-aged children are the primary drivers of transmission, the…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Apr 30, 2026 15:51 UTC
-
Brain injury breakthrough? personalized blood pressure targets tested for first time
Disease control Not yet recruitingAfter severe traumatic brain injury, adequate blood flow to the brain is essential for recovery. This depends on arterial blood pressure, yet intensive care units apply fixed targets to all patients - treating every brain and patient the same. This study aims to change that. With…
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated May 07, 2026 17:21 UTC
-
New hope for histoplasmosis: shorter, stronger drug regimens under trial
Disease control Not yet recruitingThe purpose of the study is threefold: 1. Assess the safety and efficacy of a single high-dose intravenous (LAmB 10mg/kg) compared to the SOC daily dosing (3mg/kg) of the same medication for induction therapy in moderate to severe histoplasmosis. 2. Assess the safety and efficac…
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
New hope for aggressive brain tumors: experimental combo targets first recurrence
Disease control Not yet recruitingApproximately 58-68 total subjects will be enrolled. In the first stage, 10 response evaluable subjects (either IDHwt or IDHm Grade 4 astrocytoma) will be enrolled. If 1 or more of the first 10 response evaluable subjects achieve an objective response, 19 further subjects may be …
Phase: PHASE1, PHASE2 • Sponsor: Starlight Therapeutics Inc. • Aim: Disease control
Last updated May 07, 2026 17:23 UTC
-
Bone-Shifting surgery could heal diabetic wounds and prevent amputations
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety and clinical performance of transverse tibial bone transport in patients with chronic ischemic and diabetic lower extremity ulcers. This study will assess wound healing outcomes and limb preservation in a population with limited…
Phase: NA • Sponsor: Biodynamik, Inc • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Smart test targets pneumonia before it strikes in ICU
Prevention Not yet recruitingVentilator-associated pneumonia (VAP) remains the most common hospital-acquired infection worldwide, affecting up to 40% of mechanically ventilated patients and contributing to increased morbidity, prolonged hospital stays, and high mortality rates. Standard prevention strategies…
Phase: PHASE2 • Sponsor: University of Calgary • Aim: Prevention
Last updated May 07, 2026 17:18 UTC
-
Experimental cell therapy targets tough leukemia in small early trial
Disease control Not yet recruitingThis study is an open-label, single-arm clinical trial designed to evaluate the safety and tolerability of QH103 cell infusion in subjects with CD19-positive R/R B-ALL.
Phase: PHASE1 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Targeted drug and radiation team up to fight aggressive kidney cancer
Disease control Not yet recruitingThis randomized, open-label, multicenter phase II study is designed to compare disitamab vedotin plus radiotherapy with gemcitabine plus carboplatin as adjuvant treatment in patients with HER2-expressing upper tract urothelial carcinoma after radical nephroureterectomy (RNU). Eli…
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC
-
AI coach aims to close the hepatitis b treatment gap
Disease control Not yet recruitingThe World Health Organization (WHO) has set a target to eliminate viral hepatitis by 2030, aiming for a 90% diagnosis rate and an 80% treatment rate for chronic hepatitis B (CHB). However, as of 2024, only 26.1% of CHB infections globally have been diagnosed, and only 14.6% have …
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
Magnetic brain zaps could lift severe depression that drugs Can't touch
Symptom relief Not yet recruitingThis study will evaluate the efficacy and safety of a theta burst stimulation (TBS) protocol of repetitive transcranial magnetic stimulation (rTMS) in adults with treatment-resistant depression. Participants will be randomized to either antidepressant treatment plus active rTMS T…
Phase: NA • Sponsor: Jung-Sun Lee • Aim: Symptom relief
Last updated May 07, 2026 17:19 UTC
-
New hope for advanced lung cancer: heat therapy plus drugs tested after first treatment fails
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate progression-free survival (PFS) of microwave ablation in combination with tislelizumab and docetaxel in patients with advanced non-small cell lung cancer (NSCLC) who have progressed following first-line immunotherapy combined with…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
Could a blood injection help women with uterine scarring get pregnant?
Disease control Not yet recruitingIntrauterine adhesions (IUA) caused by endometrial basal layer injury can lead to reduced menstrual flow, infertility, recurrent pregnancy loss, and poor reproductive outcomes. Hysteroscopic adhesiolysis with uterine cavity reconstruction is the standard treatment, but women with…
Phase: NA • Sponsor: Beijing Obstetrics and Gynecology Hospital • Aim: Disease control
Last updated May 07, 2026 17:23 UTC
-
Blood test guides throat cancer therapy in new trial
Disease control Not yet recruitingThe purpose of this study is to assess risk for HPV driven oropharyngeal cancers by using HPV blood tests and clinical features (such as tumor stage and smoking status) to determine appropriate treatment to improve survival outcomes in participants with stage I, II, or III, HPV-a…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
Second chance: experimental stroke drug aims to unblock brain arteries when first treatment fails
Disease control Not yet recruitingIschemic cerebrovascular disease is a common neurological disorder with high incidence, mortality, and disability. Early reperfusion to salvage the ischemic penumbra is the cornerstone of acute ischemic stroke (AIS) treatment. Current reperfusion strategies include intravenous th…
Phase: PHASE2 • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
AI could spot breast cancer on routine chest scans
Diagnosis Not yet recruitingThe goal of this observational study is to evaluate the feasibility and effectiveness of using non-contrast chest computed tomography scans for opportunistic breast cancer screening, and to further compare its diagnostic performance with conventional imaging modalities, including…
Sponsor: Fudan University • Aim: Diagnosis
Last updated May 01, 2026 15:57 UTC
-
Every second counts: can Pocket-Sized defibrillators double cardiac arrest survival?
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to learn the feasibility of equipping the volunteer community responders (VCR) with the mobile external automated defibrillators (mAEDs) for the management of adults experiencing out-of-hospital cardiac arrest (OHCA) patients. It will also provi…
Phase: NA • Sponsor: Singapore General Hospital • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC
-
New drug combo aims to shrink esophageal tumors
Disease control Not yet recruitingThe purpose of this study is to assess the efficacy and safety of QL1706 combined with nab-paclitaxel and cisplatin in first-line therapy for patients with advanced or metastatic esophageal squamous cell carcinoma. QL1706 is a anti-PD-1 and anti-CTLA4 antibody.
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Disease control
Last updated May 04, 2026 16:21 UTC